http://www.glpharma.com Effective Antimicrobial Antibiofilm Therapies Wed, 25 Jul 2012 14:09:53 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.glpharma.com/2012/07/24/july-24-2012/ http://www.glpharma.com/2012/07/24/july-24-2012/#comments Wed, 25 Jul 2012 03:18:58 +0000 sa http://www.glpharma.com/?p=235 Great Lakes Pharmaceuticals, Inc. Announces Initiation of Clinical Study for Antimicrobial Lock Solution, B-Lock™. Beachwood, July 24, 2012 - Great Lakes Pharmaceuticals, Inc. announced today the initiation of the clinical study of the first Company product, the antimicrobial lock solution, B-Lock™. The prospective, randomized, active control clinical investigation is being conducted in 22 clinical sites in Hungary and Poland and will involve up to 400 patients on renal dialysis who require a central venous catheter for vascular access. The Company expects a wealth of clinical safety and efficacy data based on up to 45,000 catheter-days observations. If successful, the clinical data will be used for CE Mark approval in the European Union. More...PDF(56Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. Announces Initiation of Clinical Study for the Antimicrobial Lock Solution, B-Lock™.

]]> http://www.glpharma.com/2012/07/24/july-24-2012/feed/ 0 http://www.glpharma.com/2011/10/26/may-1-2008/ http://www.glpharma.com/2011/10/26/may-1-2008/#comments Wed, 26 Oct 2011 23:17:17 +0000 sa http://64.78.0.251/?p=144 Great Lakes Pharmaceuticals, Inc. Announces $2.4 Million Equity Financing Cleveland, OH, May 1, 2008 – Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds including the North Coast Angel Fund JumpStart Inc., Everett Partners, Ltd, Ohio TechAngel Fund and Case Technology Ventures. The Company intends to use the funds to finalize the pre-clinical development and initiate pivotal clinical study of B-Lock™, an antimicrobial and heparin-free antithrombotic catheter lock solution. More...PDF(42Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. Announces $2.4 Million Equity Financing

]]> http://www.glpharma.com/2011/10/26/may-1-2008/feed/ 0 http://www.glpharma.com/2011/10/26/january-30-2008/ http://www.glpharma.com/2011/10/26/january-30-2008/#comments Wed, 26 Oct 2011 22:43:15 +0000 sa http://64.78.0.251/?p=136 Great Lakes Pharmaceuticals, Inc. Announces the Signing of Exclusive License Agreements Cleveland, Ohio, (January 30, 2008) – Great Lakes Pharmaceuticals, Inc. announced today that it has entered into exclusive license agreements with The Board of Regents of The University of Texas System, acting on behalf of The University of Texas M. D. Anderson Cancer Center (“UTMDACC”), and Wake Forest University Health Sciences (“WFUHS"). More...PDF(43Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. Announces the Signing of Exclusive License Agreements

]]> http://www.glpharma.com/2011/10/26/january-30-2008/feed/ 0 http://www.glpharma.com/2011/10/23/july-26-2010-2/ http://www.glpharma.com/2011/10/23/july-26-2010-2/#comments Sun, 23 Oct 2011 17:11:30 +0000 sa http://64.78.0.251/?p=62 Great Lakes Pharmaceuticals, Inc. Announces $3.1 Million Equity Financing Led by Charter Life Sciences CLEVELAND, OH--(Marketwire - July 26, 2010) - Great Lakes Pharmaceuticals, Inc. ("Great Lakes") announced today the completion of a $3.1 million Series B equity financing led by Charter Life Sciences. More...PDF(90Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. Announces $3.1 Million Equity Financing Led by Charter Life Sciences

]]> http://www.glpharma.com/2011/10/23/july-26-2010-2/feed/ 0 http://www.glpharma.com/2011/10/23/june-29-2009/ http://www.glpharma.com/2011/10/23/june-29-2009/#comments Sun, 23 Oct 2011 17:10:41 +0000 sa http://64.78.0.251/?p=59 Great Lakes Pharmaceuticals, Inc. announces $2.6 million award from National Institutes of Health Beachwood, OH - (July 29, 2009) - Great Lakes Pharmaceuticals, Inc. announced that the Company has received a Notice of Award from the National Institutes of Health (NIH), National Heart, Lung, And Blood Institute (NHLBI) in support of the project "Development of B-Lock an antibiofilm catheter lock product". The $2.6 million grant will support efforts to move the Company's B-Lock™, an antimicrobial catheter lock solution, forward to human clinical trial testing for the prevention of infections related to central venous catheters. More... (12Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. announces $2.6 million award from National Institutes of Health

]]> http://www.glpharma.com/2011/10/23/june-29-2009/feed/ 0 http://www.glpharma.com/2011/10/23/june-30-2008/ http://www.glpharma.com/2011/10/23/june-30-2008/#comments Sun, 23 Oct 2011 17:03:42 +0000 sa http://64.78.0.251/?p=53 Great Lakes Pharmaceuticals, Inc. Receives Fast Track SBIR Grant Award from NIH Beachwood, Ohio - Jun 30, 2008 (PRN): Great Lakes Pharmaceuticals, Inc. announced today that the company has received Phase One, $ 100,000 Fast Track Small Business Innovative Research (SBIR) grant from the National Institute of Health (NIH). More...PDF(71Kb) [...]]]> Great Lakes Pharmaceuticals, Inc. Receives Fast Track SBIR Grant Award from NIH

]]> http://www.glpharma.com/2011/10/23/june-30-2008/feed/ 0